1.Shwe, MM et al. (2014) Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar. Acta Medica Okayama 68, 79–87.
2.Bruni, L et al. (2015) ICO Information Centre on HPV and Cancer (HPV Information Centre) (https://www.hpvcentre.net) Human papillomavirus and related diseases in Europe. Summary Report 2015-12-23. [Data Accessed], Institut Català d’Oncologia, Barcelona, Spain. 3.Cancer Registry of Central Serbia (http://www.batut.org.rs) (2013) Cancer incidence and mortality in Central Serbia 2011, report number 13. Institute of Public Health of Serbia “Dr Milan Jovanovic Batut”, Belgrade, Serbia. 4.Cancer Registry of Central Serbia (http://www.batut.org.rs) (2017) Cancer incidence and mortality in Central Serbia 2015, report number 17. Institute of Public Health of Serbia “Dr Milan Jovanovic Batut”, Belgrade, Serbia.
5.Syrjänen, S et al. (2012) Oral HPV infection: current strategies for prevention and therapy. Current Pharmaceutical Design 18, 5452–5469.
6.Kim, J et al. (2012) Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women. International Journal of Gynecological Cancer 22, 1570–1576.
7.Mai, S et al. (2015) Prognostic relevance of HPV infection and p16 overexpression in squamous cell anal cancer. International Journal of Radiation Oncology, Biology, Physics 93, 819–827.
8.Castellsagué, X, Bosch, FX and Muňoz, N (2002) Environmental co-factors in HPV carcinogenesis. Virus Research 89, 191–199.
9.Appleby, P et al. (2007) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16573 women with cervical cancer and 35509 women without cervical cancer from 24 epidemiological studies. The Lancet 10, 1609–1621.
10.Plummer, M et al. (2003) Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes & Control 14, 805–814.
11.Bosch, F et al. (2002) The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology 55, 244–265.
12.Tao, L et al. (2014) Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. BMC Public Health 14, 1185.
13.Capra, G et al. (2015) Analysis of persistence of human papillomavirus infection in men evaluated by sampling multiple genital sites. European Review for Medical and Pharmacological Sciences 19, 4153–4163.
14.Giuliano, AR et al. (2008) The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiology, Biomarkers and Prevention 17, 2036–2043.
15.Verteramo, R et al. (2009) Human papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infectious Diseases 9, 16.
16.Gargano, JW et al. (2012) Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy. Cancer Epidemiology, Biomarkers and Prevention 21, 111–121.
17.Prompakay, R et al. (2013) Relationship between the body mass index and abnormal Pap smears. Asian Pacific Journal of Cancer Prevention 14, 5503–5506.
18.Maruthur, NM et al. (2009) The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity (Silver Spring) 17, 375–381.
19.Lee, JK et al. (2013) Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS ONE 8, e66555.
20.Capra, G et al. (2017) Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: a referral hospital-based study in Sicily. Human Vaccines and Immunotherapeutics 8, 1839–1843.
21.Yang, DY and Bracken, K (2016) Update on the new 9-valent vaccine for human papillomavirus prevention. Canadian Family Physician 62, 399–402.
22.Gravitt, PE et al. (2000) Improved amplification of genital human papillomaviruses. Journal of Clinical Microbiology 38, 357.
23.Azzimonti, B et al. (1999) Demonstration of multiple HPV types in laryngeal premalignant lesions using polymerase chain reaction and immunohistochemistry. Journal of Medical Virology 59, 110–116.
24.Forman, D et al. (2012) Global burden of human papillomavirus and related diseases. Vaccine 30S, F12–F23.
25.Stamenkovic, M et al. (2016) High-risk human papilloma virus genotypes in cervical carcinoma of Serbian women: distribution and association with pathohistological findings. Biologicals 44, 412–416.
26.Wong, HY, Loke, AY and Chan, NH (2011) Risk factors for cervical abnormalities among Hong Kong Chinese women: a large-scale community-based cervical screening program. Journal of Women's Health 20, 53–59.
27.Louie, KS et al. (2009) Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. British Journal of Cancer 100, 1191–1197.
28.Shew, ML et al. (2006) Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Archives of Pediatrics and Adolescent Medicine 160, 151–156.
29.Cornelis, JA et al. (2003) Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papilloma virus: a randomized clinical trial. International Journal of Cancer 107, 811–810.
30.Castle, PE and Giuliano, AR (2003) Genital tract infections, cervical inflammation, and antioxidant nutrients – assessing their roles as human papillomavirus cofactors. Journal of National Cancer Institute Monographs 31, 29–34.
31.Quinónez-Calvache, EM et al. (2016) Chlamydia trachomatis frequency in a cohort of HPV-infected Colombian women. PLoS ONE 11, e0147504.
32.Castellsagué, X and Muñoz, N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis – role of parity, oral contraceptives, and tobacco smoking. Journal of National Cancer Institute Monographs 31, 20–28.
33.Hellberg, D et al. (1988) Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. American Journal of Obstetrics and Gynecology 158, 910–913.
34.Simen-Kapeu, A et al. (2008) Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scandinavian Journal of Infectious Diseases 40, 745–751.
35.Vaccarella, S et al. (2008) Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. International Journal of Epidemiology 37, 536–546.
36.Sarian, LO et al. (2009) Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study. Sexually Transmitted Diseases 36, 241–248.
37.La Vecchia, C and Boccia, S (2014) Oral contraceptives, human papillomavirus and cervical cancer. European Journal of Cancer Prevention 23, 110–112.